Huile essentielle de Camomille
Food supplement declared in France, declaration No 2019-6-15, decision dated 3 June 2019
Huile essentielle de Camomille, from SAS LABORATOIRE DE COMBE D'ASE (LABORATOIRE DAZONT), is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Chamaemelum nobile 162 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- SAS LABORATOIRE DE COMBE D'ASE (LABORATOIRE DAZONT)
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 6 gouttes
- Directions for use
- 2 gouttes, 3 fois par jour sur un support neutre (miel, sucre, huile végétale).
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Prolonged use
- Objectives stated by the manufacturer (these are not authorised claims)
- Sleep
Declaration 213412, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Chamaemelum nobile (L.) All. | Essence (sommités fleuries) | Distillation | 162 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
PRÉCAUTIONS D'EMPLOI : Tenir hors de portée des enfants. A conserver dans un endroit frais, sec et à l'abri de la lumière et de la chaleur. Les compléments alimentaires doivent être utilisés dans le cadre d'un mode de vie sain et ne pas être utilisés comme substituts d'un régime alimentaire varié et équilibré. Ne pas dépasser la dose journalière recommandée. Ce produit n'est pas un médicament. Demandez conseil à un professionnel de santé avant emploi notamment en cas d'usage pédiatrique. Déconseillé chez les femmes enceintes ou allaitantes et chez les enfants de moins de 6 ans. Pas d'utilisation prolongée.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Chamaemelum nobile (L.) All.
Read the warning, when it applies and the studies cited
Roman Chamomile - Chamaemelum Nobile
Route of administration: Oral (Wichtl 2004; Bradley 1992)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2000; Blumenthal et al. 1998).
Sources cited by Health Canada (3)
- Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS, editors. Herbal Medicine: Complete Commission E Monographs. Boston (MA): Integrative Medicine Communications; 1998.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Huile essentielle de Camomille: composition and regulation”, https://compoatlas.com/en/supplements/products/213412-huile-essentielle-de-camomille, updated 15 November 2026.